| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $7.5M | -8.1% |
| Cost of Revenue | $4.7M | -3.3% |
| Gross Profit | $2.8M | -14.9% |
| R&D Expense | $4K | -63.6% |
| SG&A Expense | $3.0M | -14.1% |
| Operating Income | -$147K | -0.4% |
| Pre-tax Income | -$88K | +63.5% |
| Income Tax | $17K | — |
| Net Income | -$105K | +56.3% |
| EPS (Basic) | $0.00 | — |
| EPS (Diluted) | $0.00 | — |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Inventory | $2.3M | +13.5% |
| Current Assets | $3.0M | +0.3% |
| Total Assets | $5.2M | -9.5% |
| Current Liabilities | $2.5M | -14.0% |
| Long-term Debt | $47K | -60.1% |
| Total Liabilities | $3.3M | -21.5% |
| Stockholders' Equity | $1.9M | +22.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$171K | +41.8% |
| Capital Expenditures | $22 | +0.0% |
| Investing Cash Flow | -$14K | — |
| Financing Cash Flow | $75K | -73.2% |
| Free Cash Flow | -$171K | +41.8% |